Skip to main content

Gas Relief Mint Flavor

Medically reviewed by Drugs.com. Last updated on Aug 10, 2020.

Dosage form: tablet, chewable
Ingredients: SIMETHICONE 80mg
Labeler: Raritan Pharmaceuticals Inc
NDC Code: 68163-111

DRxCHOICE Simethicone Gas Relief 36 Chewable Tablets

Active ingredient (in each tablet)

Simethicone 80 mg

Purpose

Antigas

Uses

Relieves:

bloating
pressure
symptoms referred to as gas

Warnings

Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Directions
thoroughly chew 1 to 2 tablets as needed after meals and at bedtime
do not exceed 4 tablets in 24 hours period except under the advice and supervision of a physician.

Other information
store at room temperature 20-25ºC (68-77ºF)
each tablets contains: calcium 60mg

Inactive ingredients

dextrose, peppermint flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, silica, tribasic calcium phosphate

Principal Display Panel

NDC 68163-111-36

DRx CHOICE

Gas Relief

Anti Gas/Simethicone 80 mg

For fast relief of Bloating, Pressure & Gas Distress

Mint Flavor

Naturally and Artificially Flavored

36 CHEWABLE TABLETS

Manufactured by: Raritan Pharmaceuticals

8 Joanna Court, East Brunswick, NJ 08816

Simethicone 36 Chewable Tablets

GAS RELIEF  MINT FLAVOR
simethicone tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68163-111
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SIMETHICONE (SIMETHICONE) SIMETHICONE80 mg
Inactive Ingredients
Ingredient NameStrength
DEXTROSE, UNSPECIFIED FORM 
PEPPERMINT 
MAGNESIUM STEARATE 
MALTODEXTRIN 
MICROCRYSTALLINE CELLULOSE 
SILICON DIOXIDE 
TRICALCIUM PHOSPHATE 
Product Characteristics
ColorWHITEScoreno score
ShapeROUNDSize13mm
FlavorPEPPERMINTImprint CodeRP111
Contains    
Packaging
#Item CodePackage Description
1NDC:68163-111-3636 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33204/17/2019
Labeler - Raritan Pharmaceuticals Inc (127602287)

 
Raritan Pharmaceuticals Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.